Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

$vTv Therapeutics (VTVT.US)$ CANTEX PHARMACEUTICALS RECEIVES...

CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF BRAIN METASTASIS FROM BREAST CANCER
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
364 Views
Comment
Sign in to post a comment